INFLUENCE OF REDUCED RENAL MASS AND ROUTE OF ADMINISTRATION ON CARDIOVASCULAR EFFECTS OF POLYVINYL ALCOHOL.
D000438:Alcohols; D000740:Anemia; D004487:Edema; D006529:Hepatomegaly; D006973:Hypertension; D006977:Hypertension, Renal; D007267:Injections; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007668:Kidney; D007674:Kidney Diseases; D008099:Liver / Q000166:cytology*; D008107:Liver Diseases; D008168:Lung; D009206:Myocardium; D009392:Nephrectomy; D010336:Pathology; D010600:Pharmacology; D010827:Physiology; D011142:Polyvinyl Alcohol; D011145:Polyvinyls; D051381:Rats; D012106:Research; D012965:Sodium Chloride; D013163:Splenomegaly; D014116:Toxicology
D000438:Alcohols; D011145:Polyvinyls; D012965:Sodium Chloride; D011142:Polyvinyl Alcohol
ALCOHOLS; ANEMIA; EDEMA; EXPERIMENTAL LAB STUDY; HEPATOMEGALY; HYPERTENSION, RENAL; INJECTIONS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; KIDNEY; LIVER CYTOLOGY; LIVER DISEASES; LUNG; MYOCARDIUM; NEPHRECTOMY; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; POLYVINYLS; RATS; SODIUM CHLORIDE; SPLENOMEGALY; TOXICOLOGIC REPORT